{"nctId":"NCT02084069","briefTitle":"Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair","startDateStruct":{"date":"2013-01"},"conditions":["Heart Valve Diseases"],"count":58,"armGroups":[{"label":"Treatment","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Atorvastatin"]},{"label":"Control","type":"PLACEBO_COMPARATOR","interventionNames":[]}],"interventions":[{"name":"Atorvastatin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Greater than 25 y/o\n* No occurrence of intra- or post-operative cardiopulmonary arrest\n* Not consuming drugs affecting atrial rhythm\n* Having sinus rhythm before surgery\n* Lack of paroxysmal atrial fibrillation history\n* Only undergo heart valve surgery\n* Lack of considerable heart ischemia needed atorvastatin use\n* Routine cares in ward, post-operative ward, and intensive care unit were done\n\nExclusion Criteria:\n\n* Lesser than 25 y/o\n* History of atrial fibrillation\n* History of taking anti-arrhythmic drugs\n* History of implementing pacemakers\n* Severe heart failure\n* Renal failure\n* Hepatic failure\n* Severe pulmonary diseases\n* Heart block or bradyarrhythmia\n* Routine cares in ward, post-operative ward, and intensive care unit were not done\n* Performing concomitant cardiac surgery except valve repair\n* Having considerable heart ischemia needed atorvastatin use","healthyVolunteers":false,"sex":"ALL","minimumAge":"25 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Atrial Fibrillation Incidence After Open Cardiac Valve Repair","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":29},"commonTop":[]}}}